CSIMarket
 


Celgene Corp  (CELG)
Other Ticker:  
 
 

CELG's Net Income Growth by Quarter and Year

Celgene's Net Income results by quarter and year




CELG Net Income (in millions $) FY 2019 FY 2018 FY 2017 FY 2016
IV Quarter December - -2,973.00 -2,990.00 428.90
III Quarter September 1,691.00 1,082.00 988.00 171.40
II Quarter June 1,571.00 1,045.00 1,061.00 598.20
I Quarter March 1,545.00 846.00 941.00 800.70
FY   4,807.00 0.00 0.00 1,999.20



CELG Net Income third quarter 2019 Y/Y Growth Comment
Celgene Corp reported Net Income rise of 56.28% year on year in the third quarter 2019, to $ 1,691.00 millions, this is lower than Celgene Corp's recent average Net Income surge of 134.8%.

Looking into third quarter 2019 results within Major Pharmaceutical Preparations industry 7 other companies have achieved higher Net Income growth. While Celgene Corp' s Net Income jump of 56.28% ranks overall at the positon no. 350 in the third quarter 2019.




CELG Net Income ( Y/Y Growth %) 2019
2018 2017 2016
IV Quarter December - - - -
III Quarter September 56.28 % 9.51 % 476.43 % -
II Quarter June 50.33 % -1.51 % 77.37 % 67.94 %
I Quarter March 82.62 % -10.1 % 17.52 % 11.38 %
FY   - - - 1.7585149169998E+18 %

Financial Statements
Celgene's third quarter 2019 Net Income $ 1,691.00 millions CELG's Income Statement
Celgene's third quarter 2018 Net Income $ 1,082.00 millions Quarterly CELG's Income Statement
New: More CELG's historic Net Income Growth >>


CELG Net Income (Quarter on Quarter Growth %)

2019
2018 2017 2016
IV Quarter December - - - 150.23 %
III Quarter September 7.64 % 3.54 % -6.88 % -71.35 %
II Quarter June 1.68 % 23.52 % 12.75 % -25.29 %
I Quarter March - - 119.4 % -
FY (Year on Year)   - - - 1.7585149169998E+18 %




Net Income third quarter 2019 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #8
Healthcare Sector #26
Overall #350

Net Income Y/Y Growth Statistics
High Average Low
2959.43 % 134.8 % -100 %
(Sep. 30, 2006)   (Mar 31 2014)
Net Income third quarter 2019 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #8
Healthcare Sector #26
Overall #350
Net Income Y/Y Growth Statistics
High Average Low
2959.43 % 134.8 % -100 %
(Sep. 30, 2006)   (Mar 31 2014)

Net Income by Quarter for the Fiscal Years 2016, 2017, 2018, 2019

Celgene's Q/Q Net Income Growth


Net Income Q/Q Growth Statistics
High Average Low
488.02 % 26.73 % -100 %
(Dec. 31, 2005)   (Mar 31 2014)


CELG's III. Quarter Q/Q Net Income Comment
Celgene Corp achieved in the III. Quarter 2019 below company average Net Income increase of 7.64% quarter on quarter, to $ 1,691.00 millions.

Although the III. Quarter 2019 CELG's Net Income quarter on quarter growth was beneath the regular , this was yet encouraging news, as the III. Quarter surge, outshines the 3.54% rise in the same quarter a year ago

Within Major Pharmaceutical Preparations industry 11 other companies have achieved higher Net Income quarter on quarter growth. While Celgene's Net Income growth quarter on quarter, overall rank is 1015.


Net Income Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #12
Healthcare Sector #67
Overall #1015
Net Income Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #12
Healthcare Sector #67
Overall #1015
Net Income Q/Q Growth Statistics
High Average Low
488.02 % 26.73 % -100 %
(Dec. 31, 2005)   (Mar 31 2014)


CELG's III. Quarter Q/Q Net Income Comment
Celgene Corp achieved in the III. Quarter 2019 below company average Net Income increase of 7.64% quarter on quarter, to $ 1,691.00 millions.

III. Quarter 2019 CELG's results appear to be paradoxical, even if lower than the ordinary increase of 26.73 %, yet it demonstrates absolute acceleration compare to the 3.54% in the III. Quarter 2018 Georgia  Smith, a business insider based in London wrote.

Within Major Pharmaceutical Preparations industry 11 other companies have achieved higher Net Income quarter on quarter growth. While Celgene's Net Income growth quarter on quarter, overall rank is 1015.


Celgene's 12 Months Net Income Growth Year on Year


Net Income TTM Growth

12 Months Ending
(Sep 30 2019)
12 Months Ending
(Jun 30 2019)
12 Months Ending
(Mar 31 2019)
12 Months Ending
(Dec 31 2018)
12 Months Ending
(Sep 30 2018)
Cumulative Net Income 12 Months Ending $ 1,834.00 $ 1,225.00 $ 699.00 $ 0.00 $ -17.00
Y / Y Net Income Growth (TTM) - - - - -
Year on Year Net Income Growth Overall Ranking # # # # #
Seqeuential Net Income Change (TTM) 49.71 % 75.25 % - - -
Seq. Net Income Growth (TTM) Overall Ranking # 374 # 181 # 0 # 0 # 694




Cumulative Net Income growth Comment
Celgene saw improvement in Net Income growth trend, posting cumulative 12 months Net Income growth of 56.28% year on year, to $ 1,834 millions if the fiscal year would have ended in Sep 30 2019.
Celgene's trailing twelve months Net Income growth was higher than company's average 0% and higher than % growth in Jun 30 2019. And, Celgene realized the fastest Net Income growth, in Major Pharmaceutical Preparations industry.
But sequential growth rate was less at 49.71 % from $1225 millions recorded in twelve months ending a quarter before Georgia  Smith added on.
Still it was evidence of strength, as the average Q/Q TTM gain stands at 31.76%. In the Sep 30 2019 period, Celgene had cumulative twelve months Net Income of $ 1,834 millions compare to net loss of $ -17 millions a year ago.
Besides CELG has regained the prosperity, it is, as of now improving fast and recording better then usual Net Income gain, from the twelve months ending in the quarter before of 49.71 % from $1225 millions.

Celgene Corp achieved highest trailing twelve month year on year Net Income growth. While overall Net Income growth ranking, remained unchanged compare to the previous quarter at no. .

Net Income TTM Q/Q Growth Statistics
High Average Low
2515.53 %
31.76 %
-1433.8 %
 

Net Income TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

Net Income TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Net Income TTM Q/Q Growth Company Ranking
Within: No.
Industry # 15
Sector # 46
S&P 500 # 374
Cumulative Net Income growth Comment
Celgene saw improvement in Net Income growth trend, posting cumulative 12 months Net Income growth of 56.28% year on year, to $ 1,834 millions if the fiscal year would have ended in Sep 30 2019.
Celgene's trailing twelve months Net Income growth was higher than company's average 0% and higher than % growth in Jun 30 2019. And, Celgene realized the fastest Net Income growth, in Major Pharmaceutical Preparations industry.
But from the previous reporting period growth rate was slower at 49.71 % from $1225 millions reported in the period from Jun 30 2019 to Sep 30 2018 Georgia  Smith continued.
Still this was confirmation of strength, while the average sequential growth is at 31.76%.
The progress was much stronger from the previous reporting period exhibited at 49.71 % jump from $1225 millions in twelve months ending a quarter before. In the Sep 30 2019 period, Celgene had cumulative twelve months Net Income of $ 1,834 millions compare to net loss of $ -17 millions a year ago.
Besides Major Pharmaceutical Preparations company has regained the profitability, the company by this time is improving fast and showing better then usual Net Income gain, from the twelve months ending in the quarter Jun 30 2019 of 49.71 % from $1225 millions.

Celgene Corp achieved highest trailing twelve month year on year Net Income growth. While overall Net Income growth ranking, remained unchanged compare to the previous quarter at no. .

Net Income TTM Q/Q Growth Statistics
High Average Low
2515.53 %
31.76 %
-1433.8 %
 


Net Income TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

Net Income TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Net Income TTM Q/Q Growth Company Ranking
Within: No.
Industry # 15
Sector # 46
S&P 500 # 374




Other Net Income Growth
Major Pharmaceutical Preparations Industry Net Income Growth Trends and Statistics
Healthcare Sector Net Income Growth Statistics
Net Income Growth Trends for overall market
CELG's Net Income Growth Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Net Income Growth
Lowest Ranking Net Income Growth
Net Income Growth for CELG's Competitors
Net Income Growth for Celgene's Suppliers
Net Income Growth for CELG's Customers

You may also want to know
CELG's Annual Growth Rates CELG's Profitability Ratios CELG's Asset Turnover Ratio CELG's Dividend Growth
CELG's Roe CELG's Valuation Ratios CELG's Financial Strength Ratios CELG's Dividend Payout Ratio
CELG's Roa CELG's Inventory Turnover Ratio CELG's Growth Rates CELG's Dividend Comparisons



Companies with similar Net Income increase for the quarter ending Sep 30 2019 within Healthcare SectorY/Y Change %Net Income for the quarter ending Sep 30 2019
Integrated Biopharma Inc96.23%$ 96.226 millions
Lifevantage Corp93.30%$ 93.304 millions
Pfizer Inc86.41%$ 86.414 millions
Abbott Laboratories70.52%$ 70.515 millions
Koru Medical Systems Inc68.62%$ 68.622 millions
Staar Surgical Company63.67%$ 63.674 millions
Orasure Technologies Inc61.54%$ 61.537 millions
Celgene Corp56.28%$ 56.285 millions
Genomic Health Inc52.92%$ 52.916 millions
Quidelortho Corp49.52%$ 49.519 millions
Zomedica Corp 48.97%$ 48.967 millions
Corcept Therapeutics Inc48.42%$ 48.419 millions
Tenax Therapeutics Inc 45.26%$ 45.264 millions
Alexion Pharmaceuticals Inc 41.31%$ 41.312 millions
Kaya Holdings Inc40.61%$ 40.607 millions
Tactile Systems Technology Inc 39.23%$ 39.233 millions
Bruker Corporation39.14%$ 39.140 millions
Lhc Group Inc 38.51%$ 38.509 millions
Carlisle Companies Incorporated38.31%$ 38.315 millions
Addus Homecare Corporation37.25%$ 37.253 millions
Ensign Group Inc36.75%$ 36.747 millions
Intuitive Surgical Inc 36.63%$ 36.635 millions
Ufp Technologies Inc 36.45%$ 36.454 millions
Hanger inc.30.26%$ 30.259 millions




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com